VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | +66.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | +33.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,000 | -40.0% | 200 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $5,000 | +25.0% | 200 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $5,000 | -58.3% | 200 | +100.0% | 0.00% | -50.0% |
| Q4 2013 | $12,000 | -61.3% | 100 | -66.7% | 0.00% | -69.2% |
| Q3 2013 | $31,000 | +19.2% | 300 | 0.0% | 0.01% | +30.0% |
| Q2 2013 | $26,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |